Upstream Bio, Inc. UPB Ratios & Valuation
| FY'25 | FY'24 | ||
|---|---|---|---|
| Profitability | |||
| Operating margin | -5,618.8%-2,338pp | -3,281.2%— | |
| Net margin | -5,026%-2,376pp | -2,650%— | |
| Returns | |||
| Return on equity | -35.4%— | —— | |
| Return on invested capital | -83.2%— | —— | |
| Efficiency | |||
| Asset turnover | 0×0.0× | 0×— | |
| Liquidity | |||
| Current ratio | 26.2×-18.5× | 44.6×+26.7× | |
| Leverage | |||
| Debt-to-equity | 0×0.0× | 0×— | |
| Per Share | |||
| Book value per share | $6.31-81.6% | $34.34+182% | |
| Valuation | |||
| Market capitalization | $346.11M-40.9% | $881.13M— | |
| Price / sales | 104.2×-151× | 371.8×— | |
| Price / book | 1.1×-0.2× | 1.9×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Upstream Bio, Inc.'s ratios come from?
- Every ratio is computed from Upstream Bio, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
